BioCentury
ARTICLE | Financial News

Aldeyra Therapeutics amends IPO

March 24, 2014 7:00 AM UTC

Aldeyra Therapeutics Inc., Burlington, Mass. Business: Autoimmune, Ophthalmic Date announced: 3/21/14 Type: IPO To be raised: Up to $27.3 million Shares: 2.3 million Price: $10-$12 Underwriter: Aegis ...